Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 101Leukemia, Myeloid, Acute 94Myelodysplastic Syndromes 88Lymphoma, Non-Hodgkin 87Leukemia 86Hodgkin Disease 75Leukemia, Lymphocytic, Chronic, B-Cell 70Multiple Myeloma 57Lymphoma, Large B-Cell, Diffuse 57Lymphoma, Follicular 52Lymphoma, Mantle-Cell 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 44Leukemia, Myeloid, Accelerated Phase 43Myeloproliferative Disorders 42Congenital Abnormalities 42Leukemia, Myelomonocytic, Chronic 40Neoplasms, Plasma Cell 39Blast Crisis 38Recurrence 32Dendritic Cell Sarcoma, Interdigitating 32Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Myelodysplastic-Myeloproliferative Diseases 26Lymphoma, T-Cell, Cutaneous 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24

Interventions

fludarabine phosphate 2fludarabine 2Busulfan 2AP 1903 reagent 2Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Glucose Tolerance Test 1Cyclosporins 1Cyclophosphamide 1Continuous Glucose Monitoring 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemoglobinopathies × Busulfan × Lymphoid × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡